Spots Global Cancer Trial Database for advanced or metastatic colorectal cancer (mcrc)
Every month we try and update this database with for advanced or metastatic colorectal cancer (mcrc) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors | NCT03616574 | Advanced or Met... Advanced or Met... | CA102N LONSURF | 18 Years - | Holy Stone Healthcare Co., Ltd | |
First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors | NCT03616574 | Advanced or Met... Advanced or Met... | CA102N LONSURF | 18 Years - | Holy Stone Healthcare Co., Ltd | |
Individual Patient Expanded Access to CA102N | NCT05274204 | Advanced or Met... | CA102N | - | Holy Stone Healthcare Co., Ltd | |
Individual Patient Expanded Access to CA102N | NCT05274204 | Advanced or Met... | CA102N | - | Holy Stone Healthcare Co., Ltd | |
Individual Patient Expanded Access to CA102N | NCT05274204 | Advanced or Met... | CA102N | - | Holy Stone Healthcare Co., Ltd | |
Individual Patient Expanded Access to CA102N | NCT05274204 | Advanced or Met... | CA102N | - | Holy Stone Healthcare Co., Ltd |